Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian company’s ...
– Oral and poster presentations to include seizure and neurodevelopmental data from POLARIS Phase 1/2 Program that support advancement of ETX101 – SOUTH SAN FRANCISCO, Calif., December 01, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback